Plasmodium liver-stage and sexual-stage cellular components

Plasmodium liver-stage and sexual-stage cellular components encompass the diverse molecular machinery and organelles utilized by malaria parasites during specific phases of their life cycle within the human host. The liver stage (exo-erythrocytic) involves the infection of hepatocytes by sporozoites, leading to massive replication or, in the case of P. vivax and P. ovale, the formation of dormant hypnozoites responsible for relapses (Nature Reviews Microbiology, 2011). The sexual stage involves the differentiation of asexual blood-stage parasites into male and female gametocytes, which are the only forms capable of infecting the mosquito vector (Journal of Infectious Diseases, 2013). Therapeutic agents targeting these stages, such as 8-aminoquinolines (primaquine, tafenoquine), aim to eliminate liver-stage parasites and prevent transmission by clearing gametocytes (The Lancet Infectious Diseases, 2019). These targets are essential for malaria eradication strategies, though drug development is complicated by the biological complexity of these stages and safety risks like hemolysis in G6PD-deficient patients (New England Journal of Medicine, 2017).

Other names

Plasmodium hepatic stagePlasmodium gametocytesLiver-stage malaria parasitesSexual-stage malaria parasitesExo-erythrocytic stage componentsHypnozoites

Drugs targeting these components act through various mechanisms, including the inhibition of the mitochondrial electron transport chain (e.g., atovaquone), the induction of oxidative stress via redox cycling (e.g., primaquine), and the inhibition of parasite protein synthesis or dihydrofolate reductase (e.g., proguanil) (Nature Reviews Drug Discovery, 2017).